ImpediMed Inc.

Founded and headquartered in Brisbane, Australia, ImpediMed is a global company with operations in the United States and Europe. We are the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. ImpediMed and our subsidiaries pioneered the use of BIS technology, producing the first commercially available BIS devices in 1990. Our L-Dex device was the first FDA-cleared medical technology to use BIS for the assessment of lymphedema. Use of L-Dex is now recommended in clinical practice guidelines of research centers and professional organizations across the country.